Why do I need three orthogonal techniques (cIEF, IEX, CZE) if one seems to resolve my main peaks?

Regulatory bodies mandate orthogonal methods to confirm the purity profile, with the combined data providing robust, quantitative evidence based on surface charge, net charge (pI), and charge-to-mass ratio.

What is the main risk of the 'quantification gap' in my acidic variant profile?

This lack of accountability poses a major regulatory risk. Creative Biolabs resolves this by using high-resolution intact mass analysis on isolated fractions, ensuring every component is characterized.

Can Creative Biolabs distinguish between a true variant and a sample preparation artifact?

Artifact minimization is integral; we use immediate buffer exchange and stabilizing steps on fractions. We also run main peak controls side-by-side to differentiate genuine process-related variants from lab-induced modifications.

Charge Variant Analysis Service

Creative Biolabs' charge variant analysis platform provides the definitive, regulatory-compliant data necessary to transform structural unknowns into actionable quality attributes. Our primary goal is to establish the critical structure-function relationship (SFR) for every charge variant, a non-negotiable requirement for regulatory submission. We move beyond simple separation to provide full chemical identity and functional impact assessment, enabling clients to define robust product specifications and seamlessly progress through development.

Background What We Can Offer Workflow Why Choose Us FAQs Customer Review Related Services Contact Us

Introduction to Charge Variant Analysis

The quality control of biotherapeutics necessitates rigorous charge variant analysis. Monoclonal antibodies are heterogeneous proteins, naturally developing charge variants through post-translational modifications (PTMs) such as deamidation (creating acidic species), C-terminal lysine cleavage (creating basic species), and glycation (addition of a sugar moiety). The functional impact of these variants is critical: a modification near the antigen-binding site (CDR) can compromise efficacy, while a change in the Fc region can alter half-life (via FcRn binding). Charge variant analysis is fundamental for defining critical quality attributes (CQAs), ensuring product safety, efficacy, and batch consistency throughout development and commercialization.

Our Unrivaled Charge Variant Analysis Commitment

Customized Method Development

We tailor capillary isoelectric focusing (cIEF), ion exchange-high-performance liquid chromatography (IEX-HPLC), and capillary zone electrophoresis (CZE) methods to the specific isoelectric point and stability characteristics of your unique macromolecule, ensuring the highest possible resolution and accuracy.

Advanced Preparative Fractionation

Our proven capability to collect and subsequently characterize individual variant fractions at semi-preparative scale is crucial for providing the definitive structural identity and functional data necessary for regulatory submissions, especially when dealing with low-abundance impurities.

Integrated MS for Full Accountability

By combining IEX fractionation with high-resolution intact mass and peptide mapping, we guarantee full structural accountability for all observed charge variants, addressing the common industry challenge of quantification gaps.

Stability and Comparability Studies

We utilize charge variant analysis as a CQA metric for forced degradation, shelf-life studies, and biosimilar comparability assessments, ensuring product integrity is maintained across all development stages.

Ready to definitively categorize your charge variants and mitigate development risk? Discover How Creative Biolabs Can Help Your Project - Request a Consultation Today

Comprehensive Workflow for Definitive Characterization

The Creative Biolabs workflow is a structured process designed to provide maximum resolution, definitive structural confirmation, and functional correlation, yielding a regulatory-ready data package.

Why Choose Creative Biolabs?

Creative Biolabs specializes in complex biotherapeutic analysis, leveraging over two decades of experience. Our unique analytical advantage is the strategic integration of orthogonal separation (cIEF, IEX, CZE) with high-resolution mass spectrometry (MS). We directly integrate IEX fractionation with intact mass analysis to solve the industry problem of underestimating acidic variants like Glycation, guaranteeing full structural accountability across all charge variants. We also offer advanced preparative fractionation to collect pure, milligram-scale variants for downstream bioactivity and potency assays, providing the mandatory multiple lines of evidence required by global quality standards.

Ready to leverage the industry's most robust charge variant analysis platform? Experience the Creative Biolabs Advantage - Get a Customized Quote Today

FAQs

Customer Review

Related Services

Creative Biolabs recommends these complementary services to further secure your product's integrity and accelerate development:

Biological Activity Testing Service

Creative Biolabs' in vitro ADEPT biological activity testing involves assessing antibody binding and cytotoxicity on cell models, plus enzyme activity assays (colorimetric, fluorescence, MS) to monitor pro-drug conversion efficiency and active drug toxicity.

Learn More →

Cellular Kinase Target Engagement Assay Service

Creative Biolabs offers cellular kinase target engagement assays to quantitatively measure inhibitor binding to kinases in intact, living cells. This service provides in vivo-predictive data for cellular potency and selectivity, de-risking drug development.

Learn More →

Creative Biolabs offers an integrated, regulatory-focused charge variant analysis solution that guarantees full structural accountability for your biologic. We provide the definitive data package necessary to manage heterogeneity, close quantification gaps, and ensure your molecule successfully navigates the path to commercialization with maximized efficacy and stability.